Long-term follow-up of spinal and bulbar muscular atrophy in Taiwan

被引:14
|
作者
Fu, Ser-Chen [1 ,2 ,3 ]
Kuo, Hung-Chou [1 ,2 ]
Chu, Chun-Che [1 ,2 ]
Wu, Yih-Ru [1 ,2 ]
Ro, Long-Sun [1 ,2 ]
Liu, Chin-San [3 ]
Huang, Chin-Chang [4 ]
机构
[1] Chang Gung Mem Hosp Linkou, Dept Neurol, Taipei, Taiwan
[2] Chang Gung Univ, Taipei, Taiwan
[3] Buddhist Tzu Chi Gen Hosp, Dept Neurol, Taipei, Taiwan
[4] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan
关键词
Kennedy disease; spinal and bulbar muscular atrophy; Taiwan; X-linked recessive bulbospinal muscular atrophy; RECESSIVE BULBOSPINAL NEURONOPATHY; ANDROGEN-RECEPTOR GENE; KENNEDY-DISEASE; NATURAL-HISTORY; CAG-REPEAT; FEATURES; FAMILY; SBMA; NEUROPATHY; EXPANSION;
D O I
10.1016/j.jfma.2012.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Purpose: Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy disease, is a rare neurodegenerative disorder presenting with insidious onset of weakness in bulbar and limb muscles. Information regarding long-term clinical and functional progression has been limited, especially for the Taiwanese population. The purpose of the study aimed to investigate early diagnosis and long-term prognosis of SBMA. Methods: We retrospectively analyzed 21 genetically confirmed SBMA patients who visited our hospital between 1993 and 2010, focusing on clinical symptoms, nerve conduction studies, and functional disability. We also analyzed the relationship between length of cytosine-adenine-guanine (CAG) repeats and age of disease onset. Results: Weakness developed at a mean age of 39 +/- 7 years (mean +/- standard deviation). The length of CAG repeats and age at onset of weakness showed inverse (but nonsignificant) correlation. The most common symptoms at initial presentation were hand tremor (86%), limb weakness (86%), and perioral fasciculation (76%). Creatine kinase (CK) was elevated in 17 out of 18 patients. Initial nerve conduction studies showed statistical difference from normal controls, especially decreased amplitudes of compound motor action potential (CMAP) and sensory nerve action potential (SNAP). Functional disability showed very slow progression, with only three patients becoming wheelchair-dependent during follow-up at a median age of 72 years. Conclusion: Patients with SBMA may present with a myriad of symptoms, including limbs weakness, tremor, muscle atrophy, and perioral fasciculations. Elevated serum CK and decreased CMAP and SNAP amplitudes were supportive laboratory findings of SBMA. Disease progression was gradual, and most patients remained functionally independent many years after the onset of weakness. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
引用
收藏
页码:326 / 331
页数:6
相关论文
共 50 条
  • [21] Intravenous and Intrathecal Onasemnogene Abeparvovec Gene Therapy in Symptomatic and Presymptomatic Spinal Muscular Atrophy: Long-Term Follow-Up Study
    Darras, Basil
    Mercuri, Eugenio
    Strauss, Kevin
    Day, John
    Chien, Yin-Hsiu
    Masson, Ricardo
    Wigderson, Melissa
    Alecu, Iulian
    Ballarini, Nicolas
    Mehl, Lesa
    Marra, Jonathan
    Connolly, Anne
    NEUROLOGY, 2023, 100 (17)
  • [22] Five year follow up of a patient with spinal and bulbar muscular atrophy treated with leuprorelin
    Shimohata, T
    Kimura, T
    Nishizawa, M
    Onodera, O
    Tsuji, S
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08): : 1206 - 1207
  • [23] Long-term follow-Up of ulcerative colitis in Taiwan.
    Wei, Shu-Chen
    Shieh, Ming-Jium
    Chang, Min-Chu
    Chang, Yu-Ting
    Wang, Cheng-Yi
    Wong, Jau-Min
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S39 - S39
  • [24] Biliary cysts in children - Long-term follow-up in Taiwan
    Lee, HC
    Yeung, CY
    Fang, SB
    Jiang, CB
    Sheu, JC
    Wang, NL
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (02) : 118 - 124
  • [25] Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study
    Werlauff, U.
    Vissing, J.
    Steffensen, B. F.
    NEUROMUSCULAR DISORDERS, 2012, 22 (12) : 1069 - 1074
  • [26] Intravenous and intrathecal onasemnogene abeparvovec gene therapy in symptomatic and presymptomatic spinal muscular atrophy (SMA): long-term follow-up study
    Darras, B.
    Mercuri, E.
    Strauss, K.
    Day, J.
    Chien, Y.
    Masson, R.
    Wigderson, M.
    Alecu, I.
    Ballarini, N.
    Mehl, L.
    Marra, J.
    Connolly, A.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S87 - S87
  • [27] LONG-TERM FOLLOW-UP OF THE PHASE 1 START TRIAL OF ONASEMNOGENE ABEPARVOVEC GENE THERAPY IN SPINAL MUSCULAR ATROPHY TYPE 1
    Mendell, J. R.
    Shell, R.
    Lehman, K. J.
    McColly, M.
    Lowes, L. P.
    Alfano, L. N.
    Miller, N. F.
    Iammarino, M. A.
    Church, K.
    Kausar, I.
    Reyna, S. P.
    Meriggioli, M.
    Kleyn, A.
    Al-Zaidy, S.
    THORAX, 2021, 76 : A10 - A10
  • [28] Spinal and Bulbar Muscular Atrophy
    Grunseich, Christopher
    Fischbeck, Kenneth H.
    NEUROLOGIC CLINICS, 2015, 33 (04) : 847 - +
  • [29] Long-Term Effects of the Luteinizing Hormone-Releasing Hormone Analogues for Spinal and Bulbar Muscular Atrophy
    Ota, Kiyobumi
    Ishikawa, Kinya
    Sobue, Gen
    Mizusawa, Hidehiro
    Katsuno, Masahisa
    Haruhiko, Bannno
    Suzuki, Keisuke
    NEUROLOGY, 2011, 76 (09) : A584 - A584
  • [30] Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study
    Hashizume, Atsushi
    Katsuno, Masahisa
    Suzuki, Keisuke
    Hirakawa, Akihiro
    Hijikata, Yasuhiro
    Yamada, Shinichiro
    Inagaki, Tomonori
    Banno, Haruhiko
    Sobue, Gen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (12): : 1026 - 1032